S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:RANI

Rani Therapeutics News Headlines

$20.67
+1.11 (+5.67%)
(As of 01/14/2022 04:00 PM ET)
Add
Compare
Today's Range
$19.35
$21.37
50-Day Range
$15.81
$35.00
52-Week Range
$9.24
$36.27
Volume
80,360 shs
Average Volume
49,454 shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Rani Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RANI and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Rani Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RANI
News Sentiment

0.45

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RANI Articles
This Week

3

1

RANI Articles
Average Week



Rani Therapeutics (NASDAQ:RANI) News Headlines Today

SourceHeadline
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Shares Gap Up to $19.56
americanbankingnews.com - January 14 at 2:38 PM
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Stock Price Up 5.9%
americanbankingnews.com - January 13 at 1:02 PM
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Shares Gap Down to $18.14
americanbankingnews.com - January 11 at 12:44 PM
finance.yahoo.com logoRani Therapeutics Appoints Lisa Rometty to Board of Directors
finance.yahoo.com - January 7 at 9:37 AM
finance.yahoo.com logoRani Therapeutics Appoints Lisa Rometty to Board of Directors
finance.yahoo.com - January 7 at 9:37 AM
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Trading 7.3% Higher
americanbankingnews.com - December 28 at 12:29 PM
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Shares Gap Up to $18.45
americanbankingnews.com - December 23 at 11:59 AM
MarketBeat logoRani Therapeutics (NASDAQ:RANI) Stock Price Up 7.8%
americanbankingnews.com - December 22 at 3:16 PM
finance.yahoo.com logoRani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update
finance.yahoo.com - November 16 at 12:10 AM
finance.yahoo.com logoRani Therapeutics Appoints Lyn Baranowski to Board of Directors
finance.yahoo.com - November 12 at 7:53 PM
finance.yahoo.com logoRani Therapeutics Appoints Lyn Baranowski to Board of Directors
finance.yahoo.com - November 12 at 7:53 PM
finance.yahoo.com logoRani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference
finance.yahoo.com - November 10 at 7:19 PM
barrons.com logoRani Therapeutics Holdings Inc.
barrons.com - October 25 at 12:17 AM
finance.yahoo.com logoRani Therapeutics Holdings, Inc. (RANI)
finance.yahoo.com - October 23 at 12:24 AM
nasdaq.com logoRani Therapeutics Holdings Inc Class A Shares Close the Day 10.6% Lower - Daily Wrap
nasdaq.com - October 7 at 1:21 PM
finance.yahoo.com logoRani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
finance.yahoo.com - September 23 at 7:46 PM
finance.yahoo.com logoRani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update
finance.yahoo.com - September 13 at 7:03 PM
finance.yahoo.com logoRani Therapeutics Announces Appointment of Eric Groen as General Counsel
finance.yahoo.com - September 9 at 9:06 AM
realmoney.thestreet.com logoRani Therapeutics Holdings, Inc. Class A
realmoney.thestreet.com - August 26 at 7:35 PM
finance.yahoo.com logoRani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - August 14 at 3:58 AM
marketwatch.com logoRani Therapeutics Up 66%
marketwatch.com - August 11 at 7:21 PM
Get Rani Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RANI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feed

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.